Clinical Case Database / Category: Case Based Discussion

Neuropsychiatric complications of systemic lupus erythematosus

Publication details

Dr Nick Barkham, Dr G Aled T Benbow
Foundation Years Journal, volume 9, issue 10, p.43 (123Doc Education, London, November 2015)

Abstract

A 26 year old woman presented with a Brown-Séquard syndrome. She was found to have transverse myelitis and features of systemic lupus erythematosus. Despite treatment she continued to have multiple relapses before developing optic neuritis. Her anti-aquaporin 4 antibodies were positive and she was therefore diagnosed with neuromyelitis optica in addition to systemic lupus erythematosus.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Dr Nick Barkham

Consultant Rheumatologist
Rheumatology Unit
New Cross Hospital
Wolverhampton Road
Wolverhampton, WV10 0QP
nick.barkham@nhs.net

Dr G Aled T Benbow (Corresponding author)

FY2 Rheumatology
Rheumatology Unit
New Cross Hospital
Wolverhampton Road
Wolverhampton
WV10 0QP
aled.benbow@nhs.net

References

1. Gono T, Takarada T, Katsumata Y, Kawaguchi Y, Yoneda Y, Yamanaka H. Neuropsychiatric systemic lupus erythematosus: pathophysiology and the future of treatment. Int. J. Clin. Rheumatol 2013, 8:585-95.
2. Jennings JE, Sundgren PC, Attwood J, McCune J, Maly P. Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance. Neuroradiology 2004, 46(1):15-21.
3. Mayer M, Cerovec M, Rados M, Cikes N. Antiphospholipid syndrome and central nervous system. Clin Neurol Neurosurg 2010, 112(7):602-8.
4. Ferreira S, D'Cruz DP, Hughes GR. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology 2005, 44(4):434-42.
5. Hanly JG, Urowitz MB, Su L, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis 2011, 70(10):1726-32.
6. Conti F, Alessandri C, Perricone C, et al. Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One 2012, 7(3):e33824.
7. Royal College of Physicians. Glucocorticoid-Induced osteoporosis: Guidelines for prevention and treatment. https://www.rcplondon.ac.uk/sites/default/files/documents/glucocorticoid-induced-osteoporosis-guideline.pdf
8. NHS England. Clinical Commissioning Policy: Disease Modifying Therapies for Patients with Multiple Sclerosis (MS). http://www.england.nhs.uk/wp-content/uploads/2013/10/d04-p-b.pdf.
9. Sedal L, Wilson IB, McDonald EA. Current management of relapsing-remitting multiple sclerosis. Intern Med J 2014, 44(10):950-7.
10. Duxbury B, Combescure C, Chizzolini C. Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis. Lupus 2013, 22(14):1489-503.
11. Hauser SL, Waubant E, Arnold DL, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008, 358(7):676-88.
12. Schulz SW, Shenin M, Mehta A, Kebede A, Fluerant M, Derk CT. Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases. Rheumatol Int 2012, 32(9):2623–7.
13. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133(2):349-61.
14. Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015, 85(2):177-89.
15. Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012, 18(1):5-10.
16. Jarius S, Wildermann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol 2014, 176(2):149–64.
17. Trebst C, Jarius S, Berthele A, et al. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol 2014, 261(1):1-16.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.